The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schizoaffective disorder: An exploratory study
در این صفحه، تعداد 142 مقاله انگلیسی از ژورنال ها و مجلات معتبر پایگاه ساینس دایرکت (ScienceDirect) درباره موضوع اختلال اسکیزوافکتیو(اسکيزوفرني عاطفی) آرشیو شده است که شما می توانید مقالات مورد نظر خود را بر اساس سال انتشار، موضوع مقاله، وضعیت ترجمه و تعداد صفحات، انتخاب نموده و دانلود فرمایید.
در صورتی که مقاله لاتین مورد نظر شما تا کنون به زبان فارسی ترجمه نشده باشد، واحد ترجمه پایگاه ISI Articles با همکاری تنی چند از اساتید و مترجمان با سابقه، آمادگی دارد آن را در اسرع وقت و با کیفیت مطلوب برای شما ترجمه نماید.
در صورتی که مقاله لاتین مورد نظر شما تا کنون به زبان فارسی ترجمه نشده باشد، واحد ترجمه پایگاه ISI Articles با همکاری تنی چند از اساتید و مترجمان با سابقه، آمادگی دارد آن را در اسرع وقت و با کیفیت مطلوب برای شما ترجمه نماید.
The association between serum creatine kinase, mood and psychosis in inpatients with schizophrenia, bipolar and schizoaffective disorders
A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder
Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment
Assessing the contribution of borderline personality disorder and features to suicide risk in psychiatric inpatients with bipolar disorder, major depression and schizoaffective disorder
Effects of integrated supported employment plus cognitive remediation training for people with schizophrenia and schizoaffective disorders
The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial
A new computerized cognitive and social cognition training specifically designed for patients with schizophrenia/schizoaffective disorder in early stages of illness: A pilot study
Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder
Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST Study)
Differences between first episode schizophrenia and schizoaffective disorder
Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder ☆
Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders
Relationship between anhedonia and impulsivity in schizophrenia, major depression and schizoaffective disorder
Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms
Distinct facial processing in schizophrenia and schizoaffective disorders
Diagnostic specificity of poor premorbid adjustment: Comparison of schizophrenia, schizoaffective disorder, and mood disorder with psychotic features
The Patient Assessment Questionnaire: Initial validation of a measure of treatment effectiveness for patients with schizophrenia and schizoaffective disorder
Emotional decision-making and its dissociable components in schizophrenia and schizoaffective disorder: A behavioural and MRI investigation
Thalamic morphology in schizophrenia and schizoaffective disorder
White matter integrity and lack of insight in schizophrenia and schizoaffective disorder
Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder
Olfactory hallucinations in schizophrenia and schizoaffective disorder: A phenomenological survey
Evaluation of the Illness Management and Recovery Scale in schizophrenia and schizoaffective disorder
Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder
Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: Cognitive impairment and clozapine treatment
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder ☆
Premorbid adjustment in schizophrenia and schizoaffective disorder
Insight into severe mental illness, hope, and quality of life of persons with schizophrenia and schizoaffective disorders
Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls
Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder
Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate
Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach ☆
Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder
Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder
A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder
Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005
Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?
Stigma, social function and symptoms in schizophrenia and schizoaffective disorder: Associations across 6 months
Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy
A preliminary study of emotion processing interference in schizophrenia and schizoaffective disorder
Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk
Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder
Differing correlates for suicide attempts among patients with schizophrenia or schizoaffective disorder in India and USA
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine
The association of the HLA in patients with schizophrenia, schizoaffective disorder, and in their biological relatives
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder
Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia
Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect
Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
Plasma amisulpride levels in schizophrenia or schizoaffective disorder
Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients
A comparison study of early non-psychotic deviant behavior in Afrikaner and US patients with schizophrenia or schizoaffective disorder
Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder
Visual processing and neuropsychological function in schizophrenia and schizoaffective disorder
Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder
Neuroanatomic characterization of schizoaffective disorder using MRI: a pilot study
The relation of “acute and transient psychotic disorder” (ICD-10 F23) to bipolar schizoaffective disorder
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder
Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills
Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder
Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special?